Niagen Bioscience, Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
ASSETS
Current assets:
Cash and Cash Equivalents, at Carrying Value $16.7m $28.2m $20.3m $27.2m $44.5m
Inventory, Net $7.9m $5.8m $8.2m $11.5m $11.7m $13.6m $14.7m $14.5m $9.2m $20.4m
Assets, Current $15.7m $57.2m $36.5m $33.5m $32.2m $48.9m $46.6m $49.5m $64.1m $96.8m
Property, Plant and Equipment, Net $3.1m $2.9m $3.6m $3.8m $3.2m
Intangible Assets, Net (Excluding Goodwill) $486k $1.7m $1.5m $1.3m $1.1m $857k $671k $510k $359k $5.7m
Operating Lease, Right-of-Use Asset $891k $1.2m $4.4m $3.5m $2.4m $1.7m $2.2m
Other Assets, Noncurrent $323k $762k $625k $723k $497k $383k $368k $425k
Additional Financial Items
Accounts Receivable, after Allowance for Credit Loss, Current $5.9m $5.3m $4.4m $2.2m $5.2m $8.5m $9.7m
Accrued Liabilities, Current $2.2m $3.6m $4.3m $4.4m $6.1m $6.5m $7.3m $9.5m $7.8m $7.7m
Assets $19.8m $62.7m $42.2m $40.2m $38.4m $57.8m $54.1m $55.0m $68.3m $106.4m
LIABILITIES AND EQUITY
Current liabilities:
Operating Lease, Liability, Current $0 $595k $589k $528k $680k $691k $982k $1.0m
Accounts Payable, Current $6.0m $3.7m $9.5m $9.6m $9.4m $10.4m $9.7m $10.2m $8.5m $10.8m
Operating Lease, Liability, Noncurrent $848k $997k $4.2m $3.5m $2.6m $1.7m $1.8m
Deferred Revenue, Noncurrent $3.9m $4.4m $4.3m $4.0m $3.3m $2.6m $2.7m
Long-term Debt, Current Maturities $0
Long-term Debt, Excluding Current Maturities $0
Liabilities, Current $8.9m $8.1m $14.4m $15.1m $16.5m $17.6m $17.9m $20.6m $17.9m $19.9m
Deferred Tax Liabilities, Net $0 $0 $0 $218k ($253k)
Liabilities $9.8m $8.9m $15.1m $19.8m $21.9m $26.1m $25.4m $26.5m $22.2m $29.9m
Commitments and Contingencies $0
Stockholders’ equity:
Common Stock, Value, Issued $38k $55k $55k $60k $62k $68k $74k $75k $77k $79k
Additional Paid in Capital $55.2m $110.4m $116.9m $142.3m $158.2m $200.6m $214.1m $218.8m $227.9m $241.0m
Retained Earnings (Accumulated Deficit) ($45.2m) ($56.6m) ($89.8m) ($121.9m) ($141.8m) ($169.0m) ($185.5m) ($190.5m) ($181.9m) ($164.5m)
Stockholders' Equity Attributable to Parent $10.0m $53.8m $27.2m $20.4m $16.4m $31.7m $28.7m $28.5m $46.1m $76.5m
Liabilities and Equity $19.8m $62.7m $42.2m $40.2m $38.4m $57.8m $54.1m $55.0m $68.3m $106.4m